Soleno Therapeutics (SLNO) Current Leases (2019 - 2026)
Soleno Therapeutics' (SLNO) quarterly Current Leases came in at $1.2 million in Q1 2026, up 93.83% year-on-year from $600000.0 in Q1 2025, and up 66.14% on a QoQ basis from $700000.0 in Q4 2025.
Soleno Therapeutics (SLNO) Current Leases (2019 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 8 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Current Leases rose 93.83% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 93.83% increase from a year earlier, with the FY2025 full-year figure at $700000.0, up 40.0% from the prior year.
- Current Leases for Q1 2026 stood at $1.2 million, up from $700000.0 in the prior quarter.
- Over the last five years, Current Leases for SLNO reached as high as $1.2 million in Q1 2026 and fell as low as $39000.0 in Q1 2023.
- Historically, Current Leases has averaged $420941.2 across 5 years, with a median of $300000.0 in 2022.
- Across the five-year window, Current Leases tumbled 87.0% in 2023 and surged 669.23% in 2024, its largest moves.
- Year by year, Current Leases stood at $155000.0 in 2022, then surged by 76.13% to $273000.0 in 2023, then jumped by 83.15% to $500000.0 in 2024, then soared by 40.0% to $700000.0 in 2025, then jumped by 66.14% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.2 million in Q1 2026, $700000.0 in Q4 2025, and $697000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 697,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 448,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 337,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 282,000.00 |
| Sep 30, 2021 | 290,000.00 |
| Jun 30, 2021 | 180,000.00 |